Three of five patients with advanced colorectal cancer responded to leronlimab, including one complete response lasting five years, according to new data.

T cells are a natural part of the immune system designed to fight infections and cancer, but in conditions like blood cancer, they may not be able to eliminate malignant cells, according to Dr.

In part 2 of “This Wasn't the Plan,” a young woman recalls her stage 4 blood cancer diagnosis and how chemotherapy revealed ...

At age 19, I was a medical student with big dreams — until stage 4 blood cancer changed everything, leading to a journey of ...

Valarie Traynham discusses some of ways her life has changed since being diagnoses with cancer, and what parts of her ...

During June, investigators reported new data that has advanced the treatment landscape for lung cancer, including new FDA ...

After years of survivorship, I’m realizing that shedding extra pounds may do more than improve comfort — it could reduce my ...

Dr. Alexandra Zaleta discusses how most cancer patients face prior authorization delays, despite 95% being approved, ...

Dr. Emre Yekedüz discusses how ASCO 2025 highlights precision medicine, biomarkers and the gut microbiome as keys to ...

Dr. Breelyn Wilky stresses the importance of expert guidance and second opinions for patients with GIST, as treatment options continue to evolve rapidly. Dr. Breelyn Wilky, director of sarcoma medical ...

Julia Stalder is the founder of DCIS Understood, a nonprofit dedicated to providing clear, accessible information about ductal carcinoma in situ (DCIS). After her own DCIS diagnosis in 2024, she ...

Diagnosed with incurable cancer in her 20s, Nathalie Jean rebuilt broken systems in public service — only to face wage theft ...